PTIP UFMylation促进了BRCA1缺乏细胞中的复制分叉降解
1Guangdong Key Laboratory for Genome Stability & Disease Prevention and Carson International Cancer Center, Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, China.
The Journal of biological chemistry
|April 24, 2024
概括
乳腺癌细胞中的同源重组缺陷可以被PARP抑制剂准. PTIP UFMylation 在停滞的复制分叉中促进DNA降解,在BRCA1缺乏的细胞中赋予化学抵抗力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 癌症研究 癌症研究
背景情况:
- 由于BRCA1/2突变导致的同源重组缺陷 (HRD) 产生了与聚--基聚合酶 (PARP) 抑制剂的合成致死性.
- 在BRCA1缺乏细胞中,PTIP调节复制叉稳定的机制尚未完全理解.
研究的目的:
- 研究UFMylation在调节BRCA1缺乏细胞中的复制叉稳定中的作用.
- 阐明PTIP在赋予化学抵抗中的机制.
主要方法:
- 在体外分析,包括化共免疫沉.
- 细胞活力测试. 细胞活力测试.
- 进行BRCA1淘汰和PTIP/UFL1耗尽研究.
主要成果:
- 复制压力会诱导PTIP UFMylation. 这种压力会导致PTIP UFMylation.
- PTIP UFMylation促进了BRCA1缺乏细胞中停滞的复制分叉的末端切除和新生的DNA降解.
- PTIP或UFL1的耗尽会降低BRCA1缺乏细胞中对PARP抑制剂的敏感性.
结论:
- PTIP UFMylation是一种新的调节复制叉稳定性的机制.
- PTIP UFMylation 在BRCA1缺乏细胞中赋予化学抵抗,提供潜在的治疗点.
相关概念视频
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
The DNA Replication Fork
35.9K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork. Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
35.9K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Translesion DNA Polymerases
10.0K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


